Psychiatry

814 questions

Question 341Question →

A 41-year-old male accountant is brought to the clinic by his partner due to a 5-week history of feeling 'completely drained.' The patient reports waking up at 3:00 AM daily, having a poor appetite with a 4.5-kg (10-lb) weight loss, and experiencing pervasive feelings of worthlessness. His medical history is notable for a psychiatric admission 7 years ago. During that time, he experienced an 8-day period of sleeping only 2 hours per night, talking rapidly, and spending his life savings on a high-risk investment because he believed he had a telepathic connection with a famous billionaire. He was hospitalized involuntarily for 10 days and discharged on a medication regimen that he discontinued a year later. His only current medication is sumatriptan, which he takes occasionally for migraines. Vital signs and physical examination are within normal limits. Mental status examination reveals psychomotor retardation and a blunted affect. Which of the following is the most appropriate next step in management?

Show answer & explanation

Answer: Begin treatment with lurasidone

Answer

Begin treatment with lurasidone
This patient is currently experiencing a major depressive episode. However, his history of an 8-day episode characterized by a decreased need for sleep, rapid speech, grandiosity, and high-risk behavior requiring hospitalization clearly indicates a past manic episode. Therefore, the correct diagnosis is Bipolar I disorder, currently in a depressed episode. The standard of care for acute bipolar depression includes initiating a medication proven effective for this specific phase, such as an evidence-based second-generation antipsychotic (e.g., lurasidone, quetiapine) or a traditional mood stabilizer (e.g., lithium). Lurasidone effectively treats bipolar depression without the risk of precipitating a manic switch.

Step-by-Step Solution

1
Evaluate the current clinical presentation.
The patient has a 5-week history of depressed mood, early morning awakening, significant weight loss, and feelings of worthlessness.
These symptoms meet the diagnostic criteria for a major depressive episode.
2
Analyze the past psychiatric history.
The patient had a distinct 8-day episode of decreased need for sleep, rapid speech, grandiosity with psychotic features (telepathic connection), and excessive risky behavior requiring hospitalization.
This presentation meets the criteria for a severe manic episode, confirming a lifelong diagnosis of Bipolar I disorder.
3
Determine the safest and most effective pharmacotherapy for the current episode.
Select a medication approved for acute bipolar depression, such as lurasidone, quetiapine, or lithium.
Lurasidone effectively treats the depressive episode without the risk of precipitating a manic switch, which is a major concern with standard antidepressant monotherapy.

Key Concept

Patients presenting with a major depressive episode must be carefully screened for a history of mania; bipolar depression should be treated with mood stabilizers or appropriate second-generation antipsychotics, avoiding antidepressant monotherapy to prevent a manic switch.
Estimated Time:1m 0s
Question 342Question →

An agitated 35-year-old woman presents to the psychiatric triage center accompanied by her sister. The patient is visibly distressed and states that her neighbors are broadcasting her thoughts over the internet. According to her sister, these symptoms began suddenly 14 days ago, shortly after the patient unexpectedly lost her job. The patient is also experiencing auditory hallucinations. She has no prior history of mental illness, takes no medications, and her urine drug screen is negative. Which of the following is the most likely diagnosis?

Show answer & explanation

Answer: Brief psychotic disorder

Answer

Brief psychotic disorder
The correct answer is brief psychotic disorder because the patient presents with positive psychotic symptoms (delusions and auditory hallucinations) that have been present for 14 days. According to diagnostic criteria, psychotic symptoms lasting between 1 day and 1 month, followed by an expected full return to premorbid functioning, confirm this diagnosis. The recent job loss also serves as a classic acute stressor often associated with this condition.

Step-by-Step Solution

1
Identify the primary clinical symptoms presented in the vignette.
The patient has delusions (neighbors broadcasting her thoughts) and auditory hallucinations.
Establishing the presence of positive psychotic symptoms is the first step in diagnosing a psychotic disorder.
2
Determine the exact duration of the psychotic symptoms.
The sister reports the symptoms began abruptly 14 days ago.
Symptom duration is the key distinguishing factor among the primary psychotic disorders.
3
Assess for concurrent medical conditions, substance use, or mood episodes.
Drug screen is negative, no medications are taken, and no mood symptoms (like severe depression or mania) are reported.
This rules out substance-induced psychosis and schizoaffective disorder.
4
Match the symptom profile and timeline to the correct diagnostic criteria.
Symptoms lasting more than 1 day but less than 1 month point exclusively to brief psychotic disorder.
Brief psychotic disorder is diagnosed when symptoms resolve within 1 month. Schizophreniform is 1-6 months, and schizophrenia is >6 months.

Key Concept

The primary differentiation between brief psychotic disorder, schizophreniform disorder, and schizophrenia is based on the duration of symptoms.
Question 343Question →

A 26-year-old woman comes to the outpatient psychiatric clinic seeking help for distressing daily routines that are interfering with her job as an accountant. Over the past six months, she has felt compelled to repeatedly check that her computer is locked, her office door is bolted, and her files are perfectly aligned before she can leave work. This routine takes her nearly three hours every evening. She recognizes that these behaviors are excessive and illogical, but she experiences overwhelming dread if she attempts to leave without completing the sequence. Her psychiatric history is significant for a severe manic episode at age 21 that required hospitalization, leading to a diagnosis of bipolar I disorder. She is currently euthymic, and her mood is well-controlled on maintenance lithium therapy. During the assessment, she expresses intense fear that she will be fired if her boss finds out about her condition, explicitly stating she wants this kept completely private. Which of the following is the most appropriate next step in management?

Show answer & explanation

Answer: Commence exposure and response prevention therapy

Answer

Commence exposure and response prevention therapy
The correct answer provides a definitive, first-line treatment for obsessive-compulsive disorder (OCD) that avoids the risks of pharmacotherapy in this specific clinical context. Exposure and response prevention (ERP) therapy involves exposing the patient to anxiety-provoking triggers (e.g., leaving the office without checking) while strictly preventing the corresponding compulsion (e.g., the checking ritual). Because this patient has a confirmed history of bipolar I disorder, prescribing the typical first-line medications for OCD, such as selective serotonin reuptake inhibitors (SSRIs), poses a significant risk of precipitating a manic switch. Therefore, a non-pharmacological, highly evidence-based psychotherapy like ERP is the safest and most appropriate initial management step.

Step-by-Step Solution

1
Identify the primary psychiatric diagnosis based on the clinical presentation.
The patient exhibits time-consuming obsessions (fears of leaving things unlocked or unaligned) and compulsions (checking rituals) with intact insight, confirming obsessive-compulsive disorder (OCD).
Accurate diagnosis is required to select the appropriate treatment algorithm.
2
Review the patient's past medical history for contraindications to standard therapies.
The patient has a history of bipolar I disorder, which makes standard OCD pharmacotherapy (antidepressant monotherapy) risky.
Antidepressants can precipitate manic episodes in patients with bipolar disorder.
3
Determine the safest and most effective first-line intervention.
Exposure and response prevention therapy is a highly effective, non-pharmacological first-line treatment for OCD that carries no risk of inducing mania.
Guidelines recommend psychotherapy, specifically ERP, as a primary treatment for OCD, particularly when medications pose significant risks.

Key Concept

Exposure and response prevention (ERP) therapy is a first-line treatment for obsessive-compulsive disorder (OCD) and is particularly indicated when first-line pharmacotherapy (SSRIs) is contraindicated, such as in patients with bipolar I disorder.
Question 344Question →

When managing patients with bipolar disorder, establishing an appropriate baseline before initiating pharmacotherapy is essential for long-term safety and adverse effect monitoring. Match each psychotropic medication below with its most critical baseline laboratory screening parameters.

Click a left item, then click its matching right item

Items

Lithium
Valproate
Carbamazepine
Olanzapine

Matches

Show answer & explanation

Answer

Lithium matches with TSH/creatinine/calcium; Valproate matches with liver function/platelets; Carbamazepine matches with CBC/sodium/HLA-B*1502; Olanzapine matches with metabolic screening.
Each correct pairing directly aligns the psychotropic medication with its most dangerous or common adverse effect profile, ensuring that pre-existing abnormalities are identified before starting a medication that could exacerbate them.

Step-by-Step Solution

1
Identify the primary mechanism of action, metabolism, and major toxicities associated with each psychotropic medication.
Lithium affects kidneys/thyroid/parathyroid; Valproate is hepatotoxic and suppresses platelets; Carbamazepine causes marrow suppression, SIADH, and dermatologic reactions; Olanzapine causes metabolic syndrome.
Understanding the organ systems most at risk of drug-induced injury directly dictates the necessary baseline monitoring.
2
Pair the identified toxicities with their corresponding baseline screening laboratory tests.
Lithium pairs with renal and endocrine tests (right_1); Valproate pairs with hepatic and coagulation parameters (right_2); Carbamazepine pairs with hematologic, electrolyte, and genetic screens (right_3); Olanzapine pairs with metabolic parameters (right_4).
To ensure a safe baseline is established before exposing the patient to the medication.

Key Concept

Baseline laboratory monitoring for pharmacotherapy in Bipolar Disorder
Question 345Question →

Match each patient's clinical presentation with the most accurate personality disorder diagnosis.

Click a left item, then click its matching right item

Items

A collegiate athlete with no history of hallucinations describes communicating with spirits through her crystals; she exhibits circumstantial speech and mentions she desires friendships, but her severe social anxiety—which stems from paranoid fears about others' intentions rather than negative self-evaluation—prevents her from forming close bonds.
A retired architect strongly opposes providing his medical history for the electronic health record, citing a rigid belief that his data will be weaponized by former colleagues; he lacks fixed delusions of control but persistently interprets neutral clinic policies as personal attacks and holds enduring grudges.
Following a superficial scrape in the waiting room, a personal trainer displays rapidly shifting, shallow emotional expression and theatrical sobbing; she actively uses her physical appearance to draw attention, flirts overtly with the triage nurse, and acts as though the on-call physician is a lifelong companion.
An office manager who recently experienced a breakup immediately began dating a new partner to secure emotional support; she frequently calls the clinic to request that the physician make mundane lifestyle decisions on her behalf, and she goes to excessive lengths to obtain nurturance, even volunteering for highly unpleasant tasks.

Matches

Show answer & explanation

Answer

Vignette 1 matches Schizotypal personality disorder; Vignette 2 matches Paranoid personality disorder; Vignette 3 matches Histrionic personality disorder; Vignette 4 matches Dependent personality disorder.
Each patient's presentation precisely aligns with the DSM-5 diagnostic criteria for a distinct personality disorder. The athlete displays Cluster A schizotypal traits (eccentricity, magical thinking, paranoid anxiety). The architect displays Cluster A paranoid traits (distrust, unjustified suspicion). The personal trainer displays Cluster B histrionic traits (theatricality, superficial intimacy, shallow shifting emotions). The office manager displays Cluster C dependent traits (submissive clinginess, indecisiveness, urgent relationship seeking).

Step-by-Step Solution

1
Analyze the first clinical presentation for specific distinguishing psychological features.
Identified magical thinking, odd speech, and paranoid-based social anxiety.
These criteria distinguish schizotypal personality disorder from avoidant personality disorder (which involves anxiety due to fear of rejection) and schizophrenia (which involves overt psychosis).
2
Analyze the second clinical presentation for patterns of interpersonal interaction.
Identified pervasive distrust, suspicion of others' motives, and perceiving benign actions as attacks.
These findings fulfill the diagnostic criteria for paranoid personality disorder.
3
Analyze the third clinical presentation for emotional expression and attention-seeking behaviors.
Identified excessive emotionality, use of appearance for attention, inappropriate flirtation, and overestimating relationship intimacy.
These behaviors are the hallmark diagnostic criteria for histrionic personality disorder.
4
Analyze the fourth clinical presentation for dependency and decision-making deficits.
Identified a pervasive need to be taken care of, urgent relationship seeking for support, and an inability to make independent decisions.
These traits are diagnostic for dependent personality disorder.

Key Concept

Distinguishing personality disorders across Clusters A, B, and C by identifying their defining diagnostic criteria and differentiating them from overlapping psychiatric conditions.
Question 346Question →

A 31-year-old woman, G1P1, is brought to the outpatient psychiatric clinic by her husband 5 weeks after an uncomplicated vaginal delivery. Over the past three weeks, she has become increasingly sleep-deprived, tearful, and severely anxious. She tearfully reveals that she is experiencing repeated, intrusive images of herself intentionally drowning her baby in the bathtub or dropping the baby out of a second-story window. She is visibly horrified by these thoughts, stating, "I love my child more than anything, and I feel like a monster for having these terrible images in my head. I would never actually do it." As a result, she absolutely refuses to bathe the infant and will not carry the baby near any stairs or windows, demanding her husband perform these tasks. Furthermore, she checks the baby's breathing up to 20 times per night. She has no prior psychiatric history, does not hear voices, and exhibits intact reality testing. She has no history of substance use. Vital signs and physical examination are unremarkable. Which of the following are the most appropriate initial steps in the management of this patient? (Select 2 answers)

Select all that apply

Show answer & explanation

Answer: Initiate treatment with a selective serotonin reuptake inhibitor; Refer the patient for cognitive-behavioral therapy with exposure and response prevention

Answer

The most appropriate initial steps in management are to initiate treatment with a selective serotonin reuptake inhibitor and refer the patient for cognitive-behavioral therapy with exposure and response prevention.
The patient's clinical presentation is classic for obsessive-compulsive disorder (OCD) with postpartum onset. She is experiencing severe, ego-dystonic intrusive thoughts (obsessions) of harming her infant, which cause her immense distress (she 'feels like a monster' and is horrified). In response to the anxiety generated by these thoughts, she engages in avoidance behaviors (refusing to bathe or carry the baby near stairs) and compulsions (checking the baby's breathing 20 times a night). Because her reality testing is completely intact, she has no actual intent to harm the infant, and she does not harbor psychotic delusions, the diagnosis is definitively OCD, not postpartum psychosis. The first-line, evidence-based management for OCD includes a combination of cognitive-behavioral therapy focusing on exposure and response prevention (ERP) and pharmacotherapy with a selective serotonin reuptake inhibitor (SSRI). Both interventions should be initiated concurrently for severe symptoms.

Step-by-Step Solution

1
Analyze the patient's symptoms and level of insight.
The patient experiences intrusive, distressing thoughts of harming her infant but is horrified by them (ego-dystonic), retains intact reality testing, and engages in avoidance and checking compulsions.
Differentiating between ego-dystonic obsessions and ego-syntonic delusions is critical in postpartum psychiatric presentations.
2
Establish the most likely diagnosis.
The diagnosis is obsessive-compulsive disorder (OCD) with postpartum onset.
The presence of obsessions (intrusive thoughts) and compulsions (checking, avoidance) without psychotic features meets DSM-5 criteria for OCD.
3
Determine the safety and ethical obligations.
The patient has no intent or plan to harm the infant; therefore, there is no imminent risk of child abuse.
Ego-dystonic thoughts in OCD do not predict violence. Mandatory reporting is ethically and legally contraindicated without a genuine threat.
4
Select the evidence-based treatment modalities.
First-line management includes SSRI pharmacotherapy and cognitive-behavioral therapy focusing on exposure and response prevention (ERP).
Combined pharmacotherapy and specific psychotherapeutic interventions yield the best outcomes for severe OCD.

Key Concept

Patients with postpartum obsessive-compulsive disorder frequently experience ego-dystonic obsessions of harming their infants. Unlike postpartum psychosis, these patients have intact reality testing, no intent to harm, and require SSRIs and exposure and response prevention therapy rather than hospitalization, antipsychotics, or child protective services involvement.
Question 347Question →

A 24-year-old male graduate student visits the campus health clinic reporting three recent episodes of intense, unprovoked terror. During these episodes, which reach maximum intensity within minutes, he experiences a racing heart, a choking sensation, tremors, and a fear of losing control. He has started avoiding large lecture halls due to the worry of having an episode in public. He has no known chronic medical conditions and takes no prescription medications. His vital signs are within normal limits. The physician suspects a primary anxiety disorder but needs to exclude physiological causes. Which of the following are the most appropriate initial diagnostic steps in management? (Select 3)

Select all that apply

Show answer & explanation

Answer: 12-lead electrocardiography; Thyrotropin (TSH) level; Urine drug immunoassay

Answer

The most appropriate initial diagnostic steps are a 12-lead electrocardiography, a thyrotropin (TSH) level, and a urine drug immunoassay.
The clinical vignette describes a patient experiencing classic panic attacks. However, panic disorder can only be diagnosed after ruling out underlying physiological causes. The standard medical workup for new-onset panic attacks includes a 12-lead electrocardiogram to rule out cardiac arrhythmias (such as paroxysmal supraventricular tachycardia), a thyrotropin (TSH) level to evaluate for hyperthyroidism, and a urine drug screen to rule out intoxication with stimulants (e.g., cocaine, amphetamines). These tests are non-invasive, cost-effective, and address the most dangerous and common mimics.

Step-by-Step Solution

1
Identify the clinical syndrome
The patient's sudden episodes of intense fear, physical symptoms (palpitations, tremors), and subsequent avoidance behavior strongly suggest panic attacks and possible panic disorder.
Recognizing the symptom cluster is required to determine the appropriate diagnostic pathway.
2
Determine necessary diagnostic exclusions
Before establishing a psychiatric diagnosis, common medical and substance-related etiologies that present with identical symptoms must be ruled out.
Panic disorder is a diagnosis of exclusion in a patient presenting with acute cardiopulmonary and autonomic symptoms.
3
Select the appropriate tests
ECG (cardiac arrhythmias), TSH (hyperthyroidism), and a drug screen (stimulant use) are chosen as the standard non-invasive workup.
These tests efficiently evaluate the most common physiological mimics of panic attacks.

Key Concept

The initial evaluation of suspected new-onset panic disorder requires excluding common medical mimics (e.g., arrhythmias, hyperthyroidism) and substance intoxication using ECG, TSH, and drug screening.
Question 348Question →

An occupational health physician evaluates a 24-year-old laboratory technician during a workplace assessment. The employee's supervisor requested the evaluation because the technician refuses to collaborate on team projects, stating that his coworkers possess 'disruptive energy fields.' During the interview, the technician avoids eye contact and speaks in a highly circumstantial and elaborate manner, frequently digressing to explain how atmospheric pressure changes alter human auras. Despite these eccentric beliefs, his speech remains logically connected, and he can be redirected to the main topic. He denies hearing voices, seeing things that others do not see, or believing that external forces are controlling his thoughts. A review of his history reveals that he has always been socially isolated and experiences intense anxiety around others that does not diminish with familiarity. His work performance in solitary tasks is excellent, and he has never experienced a major depressive or manic episode. Which of the following is the most likely diagnosis?

Show answer & explanation

Answer: Schizotypal personality disorder

Answer

Schizotypal personality disorder
This patient exhibits classic features of a Cluster A personality disorder. Specifically, his presentation is consistent with schizotypal personality disorder, defined by a long-standing pattern of social deficits, acute discomfort with close relationships, cognitive or perceptual distortions (magical thinking regarding 'auras' and 'energy fields'), circumstantial speech, and excessive social anxiety that tends to be associated with paranoid fears rather than negative judgments about self. The absence of frank delusions, hallucinations, and discrete episodic timelines rules out primary psychotic disorders.

Step-by-Step Solution

1
Analyze the patient's presenting symptoms and interpersonal behavior.
The patient demonstrates magical thinking ('disruptive energy fields', 'auras'), odd and circumstantial speech, social isolation, and severe social anxiety that does not improve with familiarity.
Identifying the cluster of odd and eccentric traits is necessary to categorize the psychiatric condition.
2
Evaluate for the presence of frank psychotic symptoms.
The patient explicitly denies auditory or visual hallucinations and lacks fixed, bizarre delusions or thought broadcasting. His speech is coherent and redirectable.
Ruling out true psychosis differentiates a personality disorder from primary psychotic disorders.
3
Assess the chronicity and timeline of the symptoms.
The traits have been present 'always' (lifelong history), representing an enduring pattern rather than an acute or subacute episodic change.
Personality disorders are characterized by pervasive, stable, and long-standing patterns of behavior starting by early adulthood, distinguishing them from illnesses defined by specific symptom durations (e.g., >6 months for schizophrenia).

Key Concept

Schizotypal personality disorder is characterized by a pervasive pattern of social and interpersonal deficits, marked by acute discomfort with close relationships, cognitive or perceptual distortions, and eccentricities of behavior, without frank psychosis.
Question 349Question →

A 34-year-old man comes to the primary care clinic complaining of dizziness, nausea, vivid nightmares, and "electric shock-like" sensations in his head for the past 3 days. He has a history of major depressive disorder, which has been well-controlled on paroxetine for the past year. During the interview, he mentions that he felt completely back to normal, so he abruptly stopped taking his medication 4 days ago. His vital signs and physical examination are unremarkable. Which of the following is the most appropriate next step in management?

Show answer & explanation

Answer: Restart paroxetine and initiate a gradual tapering schedule

Answer

Restart paroxetine and initiate a gradual tapering schedule.
The correct action is to restart paroxetine and initiate a gradual tapering schedule. This patient is experiencing antidepressant discontinuation syndrome. This syndrome typically occurs within a few days of abruptly stopping a selective serotonin reuptake inhibitor (SSRI) or serotonin-norepinephrine reuptake inhibitor (SNRI). It is particularly common with medications that have a short half-life and no active metabolites, such as paroxetine and venlafaxine. Classic symptoms include flu-like symptoms, insomnia, nausea, imbalance, sensory disturbances (often described as 'brain zaps' or electric shock-like sensations), and hyperarousal. The definitive treatment is to restart the discontinued medication, which usually resolves symptoms within 24 hours, followed by a gradual dose taper if the patient still wishes to discontinue the drug.

Step-by-Step Solution

1
Identify the underlying cause of the patient's acute symptoms.
The abrupt discontinuation of paroxetine has caused antidepressant discontinuation syndrome.
Symptoms such as dizziness, nausea, vivid dreams, and 'brain zaps' (electric shock sensations) emerging 1 to 4 days after stopping a short-acting SSRI are pathognomonic for this syndrome.
2
Determine the best therapeutic intervention.
Restart the paroxetine and then taper it slowly over several weeks.
Restarting the medication eliminates the withdrawal symptoms. A gradual taper gives the brain's serotonin receptors time to adapt, preventing the symptoms from recurring.

Key Concept

Antidepressant Discontinuation Syndrome
Question 350Question →

A 64-year-old man is evaluated in the outpatient clinic for a severe major depressive episode 3 months after suffering an acute anterior myocardial infarction. He is currently hemodynamically stable and compliant with his post-myocardial infarction medical regimen, which includes dual antiplatelet therapy. He reports pervasive anhedonia, early morning awakening, profound fatigue, and feelings of worthlessness. Over the subsequent 18 months, despite extensive medical management, his depressive disorder proves highly resistant to standard therapies, eventually precipitating a severe clinical deterioration characterized by extreme food refusal, profound dehydration, and catatonic posturing requiring emergent hospitalization.

Arrange the following psychiatric management steps in the most appropriate, evidence-based chronological sequence for this patient, from initial evaluation in the outpatient clinic to the management of his final acute decompensation.

Drag items to arrange them in the correct order

Show answer & explanation

Answer

The correct sequence is: 1) Screen for a history of mania, 2) Initiate sertraline monotherapy, 3) Augment or switch antidepressants after initial monotherapy failure, 4) Administer urgent ECT for catatonia and life-threatening inanition.
The management of major depressive disorder follows a distinct, stepped-care algorithm. Initial evaluation must strictly rule out bipolar disorder before the commencement of antidepressant therapy to avoid manic switching. Once unipolar depression is confirmed, a first-line agent is initiated; in a post-myocardial infarction patient, sertraline is the safest choice due to its lack of significant cardiovascular or QTc-prolonging effects. If the patient fails to respond after an adequate 6-8 week trial at maximum tolerated doses, the regimen is escalated either by switching to another first-line agent or adding an augmenting medication like an atypical antipsychotic. Finally, if the patient develops life-threatening complications such as severe inanition, food refusal, or catatonia, rapid definitive intervention is required, making electroconvulsive therapy (ECT) the absolute treatment of choice regardless of prior medication failures.

Step-by-Step Solution

1
Rule out bipolar disorder.
Patient is confirmed to have unipolar major depressive disorder.
Antidepressant monotherapy in an undiagnosed bipolar patient can trigger an acute manic episode.
2
Select and initiate a safe first-line antidepressant based on comorbidities.
Sertraline is chosen and titrated to a therapeutic dose for an 8-week trial.
The patient's recent myocardial infarction dictates the use of sertraline, which has the safest post-MI cardiovascular profile compared to other SSRIs (like citalopram) or TCAs.
3
Escalate therapy due to treatment resistance.
The regimen is augmented with an atypical antipsychotic or transitioned to a different antidepressant class.
Standard stepped-care algorithms require changing the mechanism of action or augmenting when an adequate trial of initial monotherapy fails.
4
Implement definitive emergent somatic therapy.
The patient is hospitalized and receives ECT.
The progression to catatonia and severe food refusal is a life-threatening psychiatric emergency that requires the rapid response rate uniquely provided by ECT.

Key Concept

Stepped-care escalation of Major Depressive Disorder (MDD) in patients with cardiovascular comorbidities, culminating in emergent ECT for catatonia.
Question 351Question →

A 24-year-old man is brought to the clinic by his sister due to significant behavioral changes. For the past week, he has been sleeping only 2 hours per night but reports feeling highly energetic. He speaks rapidly, frequently jumping from one topic to another, and recently maxed out his credit cards investing in a speculative cryptocurrency. Three weeks ago, the patient was diagnosed with generalized anxiety disorder and panic disorder, for which a daily oral medication was initiated. He has a past medical history of a severe depressive episode at age 19 that lasted for four months. His vital signs are within normal limits. Mental status examination reveals psychomotor agitation, pressured speech, and grandiose delusions. Which of the following is the most appropriate next step in management?

Show answer & explanation

Answer: Discontinue the recently initiated medication and start quetiapine

Answer

Discontinue the recently initiated medication and start quetiapine
The patient is presenting with a full manic episode (decreased sleep, pressured speech, impulsivity, grandiose delusions) that emerged three weeks after initiating pharmacological treatment for generalized anxiety disorder and panic disorder. First-line pharmacotherapy for these anxiety disorders includes selective serotonin reuptake inhibitors (SSRIs) or serotonin-norepinephrine reuptake inhibitors (SNRIs). In a patient with an underlying bipolar diathesis—suggested here by a history of severe early-onset major depression—antidepressant monotherapy can precipitate a manic switch. The most appropriate immediate management is to discontinue the offending antidepressant. Additionally, because the patient exhibits severe manic symptoms with psychotic features (grandiose delusions), initiating an antimanic medication, such as an atypical antipsychotic (e.g., quetiapine, olanzapine) or a mood stabilizer, is required to rapidly stabilize his condition.

Step-by-Step Solution

1
Identify the patient's current clinical syndrome based on presenting signs and symptoms.
The patient exhibits a decreased need for sleep, pressured speech, grandiosity, and impulsive behavior, which satisfy the DSM-5 criteria for a manic episode.
Accurate syndrome identification is required before establishing etiology.
2
Determine the etiology of the manic episode by correlating the symptom timeline with recent interventions.
The manic episode began shortly after starting a daily medication for generalized anxiety and panic disorders (most likely an SSRI or SNRI). Given his history of early-onset depression, this points to an antidepressant-induced manic switch.
Understanding that the mania is iatrogenic dictates a different management pathway than spontaneous mania.
3
Select the appropriate pharmacological intervention for medication-induced mania with severe features.
The offending antidepressant must be immediately discontinued. Because the patient has severe symptoms (grandiose delusions, severe agitation), initiation of an antimanic agent such as a second-generation antipsychotic (e.g., quetiapine) is indicated.
Stopping the trigger is the definitive treatment, while an antipsychotic rapidly controls severe psychotic and manic symptoms.

Key Concept

Management of antidepressant-induced mania in patients treated for anxiety disorders
Estimated Time:1m 30s
Question 352Question →

A 28-year-old man is diagnosed with schizophrenia, and the psychiatric team is planning his long-term pharmacological management. Arrange the following interventions in the correct chronological sequence according to standard evidence-based guidelines, progressing from initial therapy to the management of highly refractory illness.

Drag items to arrange them in the correct order

Show answer & explanation

Answer

The correct sequence of treatment for schizophrenia is: 1) Initiate monotherapy with a first-line antipsychotic, 2) Trial a different first-line antipsychotic, 3) Initiate clozapine monotherapy, 4) Augment clozapine.
The standard pharmacological step-up therapy for schizophrenia begins with a trial of a first-line agent. If there is no response, a second trial with a different first-line agent is required. Establishing treatment-resistant schizophrenia necessitates failing two different standard antipsychotics. Once this criteria is met, clozapine is the definitive next step. Should clozapine fail to provide remission, augmentation strategies such as ECT are employed.

Step-by-Step Solution

1
Determine the appropriate initial therapy for newly diagnosed schizophrenia.
Monotherapy with a first-line antipsychotic is selected as the starting point.
Guidelines recommend starting with a single first- or second-generation antipsychotic due to their favorable efficacy-to-side-effect profile compared to clozapine.
2
Identify the next best step for a patient who fails the initial medication.
A trial of a different first-line antipsychotic is sequenced next.
Treatment-resistant schizophrenia requires the failure of two different medications, so a second standard trial must be attempted before advancing to high-risk agents.
3
Identify the criteria for initiating clozapine.
Clozapine monotherapy is sequenced after two failed antipsychotic trials.
Clozapine is highly effective but carries severe risks (e.g., agranulocytosis, myocarditis), reserving its use strictly for treatment-resistant cases.
4
Determine the management approach for clozapine non-response.
Clozapine augmentation (e.g., with ECT) is placed last in the sequence.
When a patient fails to respond adequately to clozapine, evidence supports augmentation with ECT or another pharmacological agent as a salvage therapy.

Key Concept

The step-wise pharmacological management algorithm for treatment-resistant schizophrenia.
Question 353Question →

Match the following brief clinical presentations with their most appropriate DSM-5 psychiatric diagnosis.

Click a left item, then click its matching right item

Items

A patient experiences 7 months of excessive, uncontrollable worry about various aspects of daily life, accompanied by muscle tension and fatigue.
A patient develops intrusive memories, negative mood, avoidance, and hyperarousal exactly 2 weeks after surviving a severe motor vehicle collision.
A patient experiences recurrent, unexpected episodes of intense fear reaching a peak within minutes, followed by persistent concern about having future episodes.
A patient actively avoids speaking in meetings or eating in public due to a persistent, intense fear of being negatively evaluated by others for the past 8 months.

Matches

Show answer & explanation

Answer

Match the clinical presentations to their respective diagnoses based on core symptoms and timeline criteria: 7 months of excessive worry aligns with Generalized anxiety disorder; 2 weeks of post-trauma symptoms aligns with Acute stress disorder; unexpected panic attacks with anticipatory anxiety aligns with Panic disorder; and 8 months of fear of scrutiny aligns with Social anxiety disorder.
Each clinical vignette provides specific symptom clusters and duration timelines that uniquely satisfy the DSM-5 diagnostic criteria for only one of the provided disorders. The key differentiators are the nature of the anxiety (worry vs. panic vs. social evaluation) and the exact duration of symptoms.

Step-by-Step Solution

1
Analyze the core symptom for each presentation.
Presentation 1 features excessive worry. Presentation 2 features post-trauma symptoms. Presentation 3 features unexpected panic attacks. Presentation 4 features fear of social scrutiny.
Identifying the primary symptom cluster isolates the specific class of psychiatric disorder (e.g., anxiety vs. trauma-related).
2
Evaluate the symptom duration for each presentation against DSM-5 criteria.
Presentation 1 is >6 months (meets GAD criteria). Presentation 2 is <1 month (meets acute stress disorder, not PTSD). Presentation 3 involves anticipatory concern after attacks (meets panic disorder). Presentation 4 is >6 months (meets SAD criteria).
Duration thresholds are essential in psychiatry to distinguish between normal acute reactions, temporary disorders, and chronic conditions.

Key Concept

Diagnosis of anxiety and trauma-related disorders requires identifying the core fear/symptom and accurately applying DSM-5 timeline criteria.
Question 354Question →

A 32-year-old male landscape architect is evaluated in the emergency department after his husband called emergency services. The patient has refused to eat for three days and states he feels "hollow and hopeless." He reports a 4-week history of severe anhedonia, hypersomnia, and a 5 kg5 \text{ kg} weight gain. Four years ago, he experienced a 3-week period where he slept only 3 hours per night, spoke rapidly, and recklessly spent his life savings on a failing business venture. He is currently on day 8 of a 10-day course of oral linezolid for a methicillin-resistant Staphylococcus aureus (MRSA) cellulitis. Vital signs are within normal limits. Mental status examination reveals psychomotor retardation and a blunted affect, but he is alert, oriented, and answers questions coherently. He denies hallucinations or delusions. Laboratory studies show a thyroid-stimulating hormone (TSH) level of 3.9 \muU/mL3.9 \text{ \mu U/mL} (reference: 0.4−4.2 \muU/mL0.4-4.2 \text{ \mu U/mL}) and a free T4 of 1.2 ng/dL1.2 \text{ ng/dL} (reference: 0.8−2.7 ng/dL0.8-2.7 \text{ ng/dL}). Which of the following is the most appropriate next step in management?

Show answer & explanation

Answer: Initiate quetiapine

Answer

Initiate quetiapine
The correct intervention is to initiate quetiapine. This patient presents with an acute depressive episode but has a clear history of a manic episode (decreased sleep, rapid speech, reckless spending resulting in severe financial impairment), establishing a diagnosis of Bipolar I Disorder. The first-line pharmacological treatments for acute bipolar depression include certain second-generation antipsychotics (quetiapine, lurasidone, cariprazine) or mood stabilizers (lithium, valproate). Quetiapine effectively targets bipolar depression without the risk of inducing a manic switch. Furthermore, it is safe to use with his current linezolid therapy, avoiding the severe risk of serotonin syndrome that standard antidepressants would pose.

Step-by-Step Solution

1
Diagnose the current psychiatric episode based on the clinical presentation.
The patient is experiencing a severe Major Depressive Episode (anhedonia, hypersomnia, weight gain, psychomotor retardation).
Identifying the current syndrome is required to target acute therapy.
2
Analyze the psychiatric history for prior mood episodes.
The patient had a discrete 3-week episode of decreased need for sleep, rapid speech, and reckless behavior causing severe impairment (loss of life savings).
This confirms a history of a Manic Episode, establishing the overarching diagnosis of Bipolar I Disorder.
3
Evaluate the patient's current medication list for potential pharmacological interactions.
The patient is taking linezolid, which possesses reversible monoamine oxidase inhibitor (MAOI) activity.
MAOIs interact fatally with serotonergic agents (like SSRIs), causing Serotonin Syndrome.
4
Select the safest and most effective pharmacotherapy for Bipolar I Depression.
Quetiapine is selected.
Quetiapine is FDA-approved for bipolar depression, does not induce manic switching (unlike SSRIs), and avoids the severe serotonergic interactions associated with linezolid.

Key Concept

The management of acute bipolar depression requires mood-stabilizing agents (such as quetiapine, lurasidone, or cariprazine) and strict avoidance of antidepressant monotherapy to prevent manic switching. Comorbid medications, such as linezolid (an MAOI), must also be evaluated to avoid fatal drug interactions.
Estimated Time:2m 0s
Question 355Question →

A young adult with previously undiagnosed psychiatric illness presents to emergency services exhibiting profound psychomotor agitation, persecutory delusions, and command hallucinations. Over the next two years, his condition proves exceptionally difficult to manage, eventually resulting in a life-threatening pharmacological complication. Based on established psychiatric guidelines, arrange the following clinical interventions in the chronological order they would be correctly implemented for this patient's evolving clinical course.

Drag items to arrange them in the correct order

Show answer & explanation

Answer

The correct sequence begins with non-pharmacological de-escalation, followed by intramuscular agents for failed de-escalation, then a first-line oral antipsychotic trial, progressing to clozapine for treatment resistance, and finally stopping the agent to check the absolute neutrophil count for clozapine-induced agranulocytosis.
The algorithmic approach to schizophrenia begins with the least restrictive means to control acute agitation (environmental and verbal de-escalation), escalating to chemical restraints (IM haloperidol/lorazepam) only if unsuccessful. Once the acute crisis is stabilized, first-line long-term maintenance requires a full 4-to-6-week trial of an oral second-generation antipsychotic (e.g., risperidone). Treatment-resistant schizophrenia is formally diagnosed only after two failed adequate trials, which then strongly indicates the initiation of clozapine. Finally, a known, life-threatening complication of clozapine therapy is agranulocytosis; any signs of systemic infection require immediate drug cessation and absolute neutrophil count (ANC) testing.

Step-by-Step Solution

1
Address acute agitation using the least restrictive means.
Employ verbal de-escalation techniques and transition the patient to a low-stimulus environment.
Current psychiatric guidelines mandate attempting non-pharmacological interventions first to preserve patient autonomy and avoid medication side effects.
2
Utilize chemical restraint for severe, refractory agitation.
Administer a combination of intramuscular haloperidol, lorazepam, and benztropine.
When verbal de-escalation fails and the patient poses an imminent risk, IM high-potency antipsychotics and benzodiazepines are required. Benztropine prevents acute dystonia.
3
Establish a baseline maintenance therapy.
Initiate a scheduled regimen of oral risperidone and evaluate therapeutic efficacy over a 4-to-6-week period.
Following stabilization, a newly diagnosed patient should undergo a 4-to-6-week trial of a first-line oral second-generation antipsychotic.
4
Manage treatment-resistant schizophrenia.
Prescribe clozapine with mandatory enrollment in a Risk Evaluation and Mitigation Strategy (REMS) program.
Failure of the initial risperidone trial and a subsequent trial confirms treatment-resistant schizophrenia, which is the primary indication for clozapine.
5
Address severe clozapine-associated adverse effects.
Immediately discontinue psychotropic agents and obtain a stat absolute neutrophil count.
A life-threatening complication of clozapine is agranulocytosis. The sudden onset of infectious symptoms requires immediate cessation of the drug and evaluation of the ANC.

Key Concept

Algorithmic stepwise management of schizophrenia from acute agitation to treatment resistance and the management of severe pharmacologic complications.
Estimated Time:2m 0s
Question 356Question →

For each of the following patient vignettes, select the most accurate personality disorder diagnosis.

Click a left item, then click its matching right item

Items

A 29-year-old software developer works night shifts to avoid coworkers. He spends weekends alone, expresses no desire for romantic involvement, and appears indifferent to the praise he receives for his coding efficiency.
A 22-year-old college student constantly texts her sister for advice on everyday decisions. She recently tolerated an abusive relationship because she felt unable to survive alone and rapidly sought a new partner after breaking up.
A 40-year-old surgical fellow meticulously re-sterilizes instruments, causing schedule delays. He refuses to delegate tasks to interns because they cannot meet his exact standards and spends free time organizing textbooks instead of relaxing.
A 26-year-old barista presents with superficial forearm lacerations after her therapist announced a vacation. She alternates between idealizing the triage nurse and verbally attacking the physician, describing feelings of chronic emptiness.

Matches

Show answer & explanation

Answer

The vignettes correctly match with Schizoid, Dependent, Obsessive-Compulsive, and Borderline Personality Disorders, respectively.
Each vignette provides classic diagnostic criteria for specific personality disorders. Vignette 1 describes the solitary nature and indifference of schizoid personality disorder. Vignette 2 highlights the clinging behavior and intense fear of separation seen in dependent personality disorder. Vignette 3 illustrates the ego-syntonic perfectionism and rigidity of obsessive-compulsive personality disorder. Vignette 4 demonstrates the unstable relationships, fear of abandonment, and self-harm typical of borderline personality disorder.

Step-by-Step Solution

1
Analyze the first vignette for core interpersonal traits.
The patient shows profound social detachment, preference for solitary activities, and indifference to others' opinions.
Identifying the genuine lack of desire for relationships points away from avoidant personality disorder and confirms schizoid traits.
2
Examine the second vignette focusing on relational dependency.
The patient displays an excessive need to be cared for, indecisiveness without reassurance, and intense fear of being alone.
These deeply ingrained dependent and clinging behaviors confirm a diagnosis of dependent personality disorder.
3
Evaluate the third vignette regarding work habits, control, and flexibility.
The patient is preoccupied with perfectionism, refuses to delegate, and sacrifices leisure for extreme organization.
This rigidity and need for control characterize obsessive-compulsive personality disorder, differentiating it from true obsessive-compulsive disorder (OCD) which involves ego-dystonic obsessions.
4
Assess the fourth vignette for emotional regulation and relationship stability.
The patient exhibits self-harm in response to perceived abandonment, splitting behaviors, and chronic emptiness.
These intense, unstable emotions and boundary issues are classic hallmark features of borderline personality disorder.

Key Concept

Differentiating the core clinical features and interpersonal dynamics of Cluster A, B, and C personality disorders.
Estimated Time:1m 30s
Question 357Question →

Match each atypical patient clinical presentation with the most likely substance intoxication syndrome.

Click a left item, then click its matching right item

Items

A 22-year-old man rapidly alternates between a profound, unarousable coma and severe, combative agitation. He exhibits significant bradycardia but awakens spontaneously and completely after 3 hours.
A 26-year-old man exhibits extreme agitation, severe paranoia, and violent behavior lasting for over 48 hours. Routine urine toxicology is negative, and he requires continuous intravenous sedation.
A 17-year-old boy presents with severe ataxia, dissociative visual hallucinations, hyperreflexia, and inducible ankle clonus after consuming a large quantity of an over-the-counter liquid.
A 15-year-old boy presents with ataxia and slurred speech. Examination reveals an erythematous, scaling perioral rash. Laboratory studies demonstrate a normal anion gap metabolic acidosis and hypokalemia.

Matches

Show answer & explanation

Answer

The correct matches are: the patient with alternating coma and agitation matches GHB; the patient with prolonged 48-hour delirium matches synthetic cathinones; the patient with ataxia and clonus matches dextromethorphan; and the patient with a perioral rash and metabolic acidosis matches toluene.
Each clinical vignette contains pathognomonic features that definitively link to only one substance. GHB uniquely causes alternating coma and agitation. Synthetic cathinones cause unusually prolonged delirium not seen with standard stimulants. Dextromethorphan uniquely combines NMDA antagonism with serotonin syndrome. Toluene uniquely causes Type 1 RTA alongside typical inhalant effects.

Step-by-Step Solution

1
Analyze the first presentation for highly specific temporal and neurologic features.
Identify the rapid cycling between profound coma and combativeness, resolving in a few hours.
GHB has a very narrow therapeutic index and unique receptor pharmacodynamics (GABA-B) that cause rapid clinical state shifts from deep central nervous system depression to severe agitation.
2
Evaluate the second presentation focusing on duration and toxicology results.
Identify the prolonged multi-day delirium with negative standard urine toxicology.
Amphetamine analogs found in synthetic cathinones evade standard immunoassay detection and have significantly longer half-lives than traditional stimulants like cocaine.
3
Correlate the third presentation's mix of dissociative and neuromuscular symptoms.
Recognize the combination of dissociation (NMDA antagonism) and hyperreflexia/clonus (serotonergic toxicity).
Dextromethorphan is the only commonly abused over-the-counter substance that simultaneously acts as an NMDA antagonist and a serotonin reuptake inhibitor.
4
Analyze the fourth presentation's dermatological and acid-base abnormalities.
Connect the perioral rash with the laboratory finding of normal anion gap metabolic acidosis and hypokalemia.
Chronic or subacute toluene inhalation causes distal renal tubular acidosis (Type 1 RTA) and a characteristic perioral contact dermatitis.

Key Concept

Differentiating atypical or lesser-known substance intoxications through unique clinical identifiers (e.g., fluctuating consciousness, prolonged duration, specific toxidrome combinations, and acid-base disturbances).
Question 358Question →

Match each patient's core clinical presentation and disease progression pattern to the most likely neurocognitive disorder diagnosis.

Click a left item, then click its matching right item

Items

Insidious onset of prominent short-term memory impairment and word-finding difficulties, with later development of apraxia and agnosia.
Fluctuating cognitive impairment, recurrent well-formed visual hallucinations, and spontaneous onset of parkinsonian motor features.
Early and prominent behavioral changes, including severe disinhibition, loss of empathy, and hyperorality, with relative sparing of memory.
Stepwise decline in executive function and processing speed, typically accompanied by focal neurological deficits on physical examination.

Matches

Show answer & explanation

Answer

The presentations match as follows: isolated memory loss to Alzheimer disease; fluctuating cognition with hallucinations to Lewy body dementia; early disinhibition to Frontotemporal dementia; and stepwise decline to Vascular dementia.
Each neurocognitive disorder has a distinct initial clinical signature based on the specific regions of the brain affected early in the disease process. Alzheimer disease typically begins in the medial temporal lobe, disrupting memory. Frontotemporal dementia affects the frontal and temporal lobes first, altering behavior and language. Lewy body dementia involves widespread cortical and subcortical alpha-synuclein deposition, leading to hallucinations and parkinsonism. Vascular dementia depends on stroke location but classically causes a stepwise decline corresponding to discrete ischemic events.

Step-by-Step Solution

1
Analyze the first clinical presentation
Identified predominant early short-term memory loss and apraxia
Memory deficits followed by general cortical signs point directly to Alzheimer disease.
2
Analyze the second clinical presentation
Identified visual hallucinations, fluctuating cognition, and parkinsonism
These three symptoms form the core diagnostic criteria for Lewy body dementia.
3
Analyze the third clinical presentation
Identified behavioral disinhibition, apathy, and hyperorality without early memory loss
Severe personality and behavioral changes preceding memory deficits strongly indicate Frontotemporal dementia.
4
Analyze the fourth clinical presentation
Identified stepwise decline and focal neurological deficits
A stepwise clinical course implies sequential infarcts, pointing to Vascular dementia.

Key Concept

Differentiation of major neurocognitive disorders based on their distinct initial clinical presentations and underlying affected brain regions.
Question 359Question →

A 35-year-old male business executive presents to a new primary care physician to establish care. Upon entering the examination room, he immediately complains that the clinic's waiting area is "substandard for someone of my caliber" and insists he should not have been required to wait. During the interview, he boasts extensively about his "unmatched genius" in corporate strategy and demands referrals only to "top-tier, world-renowned specialists" for his mild lower back pain. He expresses intense envy toward a rival executive who recently received a prestigious industry award. The patient notes that yesterday, upon hearing about his rival's award, he felt a deep sense of emptiness and experienced a 2-hour episode of intense paranoia, believing his colleagues were conspiring to ruin his career. This paranoia completely resolved after he successfully led a board meeting later that afternoon. His medical history is notable for occasional low mood, for which he takes fluoxetine. Vital signs are within normal limits. Laboratory results show a thyroid-stimulating hormone (TSH) level of 1.8 µU/mL and a normal free T4. Which of the following is the most likely diagnosis?

Show answer & explanation

Answer: Narcissistic personality disorder

Answer

Narcissistic personality disorder
The correct diagnosis is Narcissistic Personality Disorder (NPD). This patient exhibits a pervasive pattern of grandiosity, a need for admiration, a sense of entitlement, and envy of others. When faced with a threat to their self-esteem (a 'narcissistic injury', such as a rival's success), patients with NPD can experience intense feelings of emptiness or develop severe, transient stress-related paranoid ideation. Crucially, these paranoid episodes are fleeting (lasting minutes to hours) and resolve once the patient's self-worth is validated (e.g., successfully leading a board meeting).

Step-by-Step Solution

1
Analyze the patient's interpersonal behavior and core personality traits.
The patient demonstrates grandiosity, entitlement, belief that he is 'special' (demanding world-renowned specialists), and intense envy of others.
Identifying pervasive character traits is essential for distinguishing Cluster B personality disorders from acute Axis I pathologies.
2
Evaluate the acute symptoms in the context of stressors.
The patient experienced a 2-hour episode of paranoia triggered by a 'narcissistic injury' (his rival winning an award), which resolved rapidly.
Determining the duration and trigger of psychotic symptoms differentiates transient stress-related paranoia seen in personality disorders from primary psychotic disorders.
3
Rule out medical and medication-induced etiologies.
Normal thyroid labs rule out hyperthyroidism. Absence of fever, clonus, and autonomic instability rules out serotonin syndrome despite SSRI use.
Psychiatric diagnoses are diagnoses of exclusion; physiological causes of altered mental status must be eliminated first.

Key Concept

Patients with Narcissistic Personality Disorder exhibit pervasive grandiosity and lack of empathy, and they may experience transient, stress-related paranoid ideation following a narcissistic injury.
Question 360Question →

Police officers escort a 27-year-old man to the acute care triage desk after he was found highly agitated outside a nightclub. Witnesses reported seeing him ingest an unknown substance earlier in the evening. He is uncooperative, heavily diaphoretic, and clenching his jaw. Vital signs show a temperature of 37.7°C (99.9°F), pulse of 142/min, respirations of 24/min, and blood pressure of 188/110 mmHg. His pupils are dilated but reactive to light. Cardiopulmonary examination reveals rapid, regular heart sounds and clear lungs. He exhibits no focal motor deficits. A 12-lead electrocardiogram demonstrates sinus tachycardia. Which of the following is the best initial step in managing this patient's condition?

Show answer & explanation

Answer: Administer intravenous lorazepam

Answer

Administer intravenous lorazepam
The correct answer is to administer intravenous lorazepam. This patient's presentation of severe agitation, diaphoresis, mydriasis, hypertension, and tachycardia following illicit substance ingestion is highly characteristic of a sympathomimetic toxidrome, most commonly due to cocaine. The first-line and most appropriate initial treatment for cocaine-induced psychomotor agitation and cardiovascular toxicity is a benzodiazepine (e.g., lorazepam or diazepam). Benzodiazepines enhance GABAergic inhibition, effectively decreasing central sympathetic outflow. This pharmacological action not only safely calms the patient but also lowers both blood pressure and heart rate, preventing severe complications such as myocardial ischemia or seizures.

Step-by-Step Solution

1
Identify the underlying clinical syndrome based on the patient's history and vital signs.
The combination of severe agitation, marked hypertension, tachycardia, diaphoresis, and mydriasis after nightclub substance use indicates a sympathomimetic toxidrome (most likely cocaine intoxication).
Establishing the correct toxidrome directly guides the immediate medical stabilization and pharmacological management.
2
Select the safest and most effective initial medication to reverse the sympathomimetic effects.
Intravenous lorazepam (a benzodiazepine) is identified as the first-line therapy.
Benzodiazepines reduce central sympathetic outflow, thereby alleviating agitation, lowering blood pressure, and reducing heart rate without risking unopposed alpha-adrenergic stimulation.

Key Concept

Benzodiazepines are the first-line pharmacological treatment for severe cocaine intoxication to control psychomotor agitation, hypertension, and tachycardia by decreasing central sympathetic outflow.
Estimated Time:1m 0s
PreviousPage 18 / 41Next
Psychiatry Practice Questions — USMLE Step 2 CK — Page 18 | Examkin